A study published in PNAS surveyed endothelial cells (ECs) of transgenic mice bearing prostate adenocarcinoma and indicated that high level of baseline activity of RhoA and ROCK1 might give rise to aberrant behaviors of prostate cancer ECs [34]. The gene discussed is RHOA; the disease is prostate cancer.